Literature DB >> 21763050

Bisphosphonate-related osteonecrosis of the jaws--an initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma.

Marcos Martins Curi1, Giuliano Saraceni Issa Cossolin, Daniel Henrique Koga, Cristina Zardetto, Silmara Christianini, Olavo Feher, Camila Lopes Cardoso, Marcelo Oliveira dos Santos.   

Abstract

PURPOSE: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a well-recognized pathologic entity that is challenging and difficult to manage. Recent literature contains several articles, with most recommending conservative management. This report describes a treatment modality for advanced cases of BRONJ that involves bone resection and autologous platelet-rich plasma (PRP). PATIENTS AND METHODS: This case series consisted of 25 patients with BRONJ lesions and a history of intravenous bisphosphonate therapy for metastatic bone diseases that did not respond to conservative treatment. All patients were surgically managed by a standardized protocol combining bone resection and PRP.
RESULTS: Of the 25 patients, 20 (80%) showed complete wound healing during follow-up. Median follow-up was 36 months. Microscopic examination showed actinomyces in 15 specimens.
CONCLUSION: BRONJ has been shown to be refractory to conservative management. Treatment of refractory BRONJ with a combination of bone resection and PRP was found to be an effective therapy in most patients and should be considered an alternative treatment modality for management of advanced cases.
Copyright © 2011 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763050     DOI: 10.1016/j.joms.2011.02.078

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  25 in total

Review 1.  Platelet-Rich Plasma Promotes Axon Regeneration, Wound Healing, and Pain Reduction: Fact or Fiction.

Authors:  Damien P Kuffler
Journal:  Mol Neurobiol       Date:  2015-06-06       Impact factor: 5.590

2.  Treatment of stage II medication-related osteonecrosis of the jaw with necrosectomy and autologous bone marrow mesenchymal stem cells.

Authors:  Pit Jacob Voss; Akihiko Matsumoto; Esteban Alvarado; Rainer Schmelzeisen; Fabian Duttenhöfer; Philipp Poxleitner
Journal:  Odontology       Date:  2017-02-20       Impact factor: 2.634

3.  Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study.

Authors:  Takuya Asaka; Noritaka Ohga; Yutaka Yamazaki; Jun Sato; Chiharu Satoh; Yoshimasa Kitagawa
Journal:  Clin Oral Investig       Date:  2016-11-11       Impact factor: 3.573

4.  Stage-related treatment concept of medication-related osteonecrosis of the jaw-a case series.

Authors:  Petra Rugani; Stephan Acham; Barbara Kirnbauer; Astrid Truschnegg; Barbara Obermayer-Pietsch; Norbert Jakse
Journal:  Clin Oral Investig       Date:  2014-12-17       Impact factor: 3.573

5.  Use of Ultrasonic Bone Surgery (Piezosurgery) to Surgically Treat Bisphosphonate-Related Osteonecrosis of the Jaws (BRONJ). A Case Series Report with at Least 1 Year of Follow-Up.

Authors:  Cornelio Blus; Serge Szmukler-Moncler; Giulio Giannelli; Gloria Denotti; Germano Orrù
Journal:  Open Dent J       Date:  2013-08-23

Review 6.  Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review.

Authors:  Larissa Fernandes Silva; Cláudia Curra; Marcelo Salles Munerato; Carlos Cesar Deantoni; Mariza Akemi Matsumoto; Camila Lopes Cardoso; Marcos Martins Curi
Journal:  Oral Maxillofac Surg       Date:  2015-12-11

7.  Pentoxifylline and tocopherol in the management of cancer patients with medication-related osteonecrosis of the jaw: an observational retrospective study of initial case series.

Authors:  Adepitan A Owosho; Cherry L Estilo; Joseph M Huryn; SaeHee K Yom
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2016-07-13

Review 8.  Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): the missing link?

Authors:  J De Ceulaer; E Tacconelli; S J Vandecasteele
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-01       Impact factor: 3.267

9.  Platelet-rich growth factor in oral and maxillofacial surgery.

Authors:  Uma Shanker Pal; Shadab Mohammad; Rakesh K Singh; Somdipto Das; Nimisha Singh; Mayank Singh
Journal:  Natl J Maxillofac Surg       Date:  2012-07

10.  Treatment of medication-related osteonecrosis of the jaws (MRONJ) with ultrasonic piezoelectric bone surgery. A case series of 20 treated sites.

Authors:  Cornelio Blus; Giulio Giannelli; Serge Szmukler-Moncler; Germano Orru
Journal:  Oral Maxillofac Surg       Date:  2016-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.